Encompass Health Total Liabilities 2012-2026 | EHC
Encompass Health total liabilities from 2012 to 2026. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Encompass Health total liabilities for the quarter ending March 31, 2026 were $4.005B, a 7.02% increase year-over-year.
- Encompass Health total liabilities for 2024 were $3.742B, a 2.73% decline from 2023.
- Encompass Health total liabilities for 2023 were $3.847B, a 0.97% increase from 2022.
- Encompass Health total liabilities for 2022 were $3.81B, a 15.48% decline from 2021.
|
Encompass Health Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $3,742 |
| 2023 | $3,847 |
| 2022 | $3,810 |
| 2021 | $4,508 |
| 2020 | $4,476 |
| 2019 | $4,388 |
| 2018 | $3,618 |
| 2017 | $3,469 |
| 2016 | $3,753 |
| 2015 | $3,827 |
| 2014 | $2,769 |
| 2013 | $2,066 |
| 2012 | $2,021 |
| 2011 | $2,070 |
|
Encompass Health Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2026-03-31 | $4,005 |
| 2025-09-30 | $3,734 |
| 2025-06-30 | $3,753 |
| 2025-03-31 | $3,760 |
| 2024-12-31 | $3,742 |
| 2024-09-30 | $3,789 |
| 2024-06-30 | $3,907 |
| 2024-03-31 | $3,869 |
| 2023-12-31 | $3,847 |
| 2023-09-30 | $3,817 |
| 2023-06-30 | $3,843 |
| 2023-03-31 | $3,822 |
| 2022-12-31 | $3,810 |
| 2022-09-30 | $3,766 |
| 2022-06-30 | $4,581 |
| 2022-03-31 | $4,496 |
| 2021-12-31 | $4,508 |
| 2021-09-30 | $4,461 |
| 2021-06-30 | $4,437 |
| 2021-03-31 | $4,499 |
| 2020-12-31 | $4,476 |
| 2020-09-30 | $4,715 |
| 2020-06-30 | $4,671 |
| 2020-03-31 | $4,341 |
| 2019-12-31 | $4,388 |
| 2019-09-30 | $4,716 |
| 2019-06-30 | $4,228 |
| 2019-03-31 | $3,967 |
| 2018-12-31 | $3,618 |
| 2018-09-30 | $3,548 |
| 2018-06-30 | $3,588 |
| 2018-03-31 | $3,499 |
| 2017-12-31 | $3,469 |
| 2017-09-30 | $3,510 |
| 2017-06-30 | $3,517 |
| 2017-03-31 | $3,725 |
| 2016-12-31 | $3,753 |
| 2016-09-30 | $3,718 |
| 2016-06-30 | $3,783 |
| 2016-03-31 | $3,784 |
| 2015-12-31 | $3,827 |
| 2015-09-30 | $3,459 |
| 2015-06-30 | $2,705 |
| 2015-03-31 | $2,938 |
| 2014-12-31 | $2,769 |
| 2014-09-30 | $2,201 |
| 2014-06-30 | $2,021 |
| 2014-03-31 | $2,057 |
| 2013-12-31 | $2,066 |
| 2013-09-30 | $2,115 |
| 2013-06-30 | $2,119 |
| 2013-03-31 | $2,169 |
| 2012-12-31 | $2,021 |
| 2012-09-30 | $2,100 |
| 2012-06-30 | $2,022 |
| 2012-03-31 | $2,060 |
| 2011-12-31 | $2,070 |
| 2011-09-30 | $2,119 |
| 2011-06-30 | $2,281 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $10.662B | $5.935B |
| Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |